NABIHEAL

Enero 2023 – diciembre 2026

Grant Agreement: 101092269

“ANTIMICROBIAL
NANOSTRUCTURED BIOMATERIALS FOR COMPLEX WOUND HEALING” 

This
project received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101092269.

The NABIHEAL project will advance on the synthesis of advanced nanostructured biomaterials as an alternative to the commonly used silver-based materials. The
project will work to produce multifunctional materials for the treatment of complex wound healing, which has become a global health problem.

Complex wounds, such as chronic wounds, are highly susceptible to microbial infection and biofilm formation, and thus difficult to treat. The most common antimicrobial products to treat these infections are based on silver. However, they have several economic, environmental and safety drawbacks. The biomaterials developed within the NABIHEAL project will offer a safer, more sustainable and more cost-effective alternative.

The project aims to obtain innovative multifunctional wound healing biomaterials using affordable EU-based manufacturing technologies. In the long term, NABIHEAL could become a game-changing alternative to silver in wound healing dressings.

The project is coordinated by the Center for Biomedical Research Network (CIBER) at the Institute of Materials Science of Barcelona (ICMAB), and the international consortium is formed by the following centers and companies: from Spain, the Center for Biomedical Research Network (CIBER) at the University of Extremadura and the University of Cantabria, the Spanish National Research Council (CSIC), Nanomol Technologies S.L. (NT), Bioiberica S.A.U (BIO), Histocell S.L (HCELL), the University of Granada (UGR), and Asphalion (ASPH); from Germany, MyBiotech GmbH (MyB) and Charité-Universitätsmedizin Berlin (CH); from Croatia, the Institute
for Medical Research and Occupational Health (IMI); from Denmark, the Aarhus University (AU); from Israel, the Technion-Israel Institute of Technology (IT); from Austria, BioNanoNet Forschungsgesellschaft mbH (BNN); and from Slovenia, the University of Maribor (UM).

Histocell will contribute to NABIHEAL with its expertise on biomaterial development based on its proprietary technology REOXCARE as well as with its deep knowledge of wound healing treatment, medical devices manufacturing and understanding of the wound market. 

Press release: https://icmab.es/new-european-project-nabiheal-in-biomaterials-for-complex-wound-healing